Helen M. Boudreau
Ms. Boudreau has 30 years experience across biotech, pharmaceuticals, consulting and banking industries. Most recently, she was Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute, a non-profit biotech.
Previously, she served as CFO for NASDAQ-listed Proteostasis Therapeutics and privately held FORMA Therapeutics, after spending 16 years in senior finance and strategy roles at Novartis and Pfizer. She currently serves on the Board of Premier, Inc., a NASDAQ-listed healthcare improvement company, as well as a private startup focused on mental health.
She holds a BA in Economics from the University of Maryland and an MBA from the Darden School at the University of Virginia.